Inactive Instrument
Quotes PHARMAGEST INTER. Euronext Paris
Stocks
FR0000077687
IT Services & Consulting
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 30/07 | Equasens Société anonyme Reports Group Revenue Results for the Second Quarter and First Half Ended 30 June 2026 | CI |
| 02/07 | Equasens Société Anonyme Announces Board Changes | CI |
Stock exchange
Euronext Paris- €
-
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| EQS | 31.05EUR | +0.49% | 3L € | ||
CBOE
| PHAp | 31.08EUR | +0.32% | 82.88T € | |
Börse Stuttgart
| PHF | 30.95EUR | +0.49% | 2.29T € | |
CBOE
| 0R9T | 32.65EUR | 0.00% | 0 € | |
Deutsche Boerse AG
| PHF | 30.35EUR | -0.16% | 0 € | |
Boerse Muenchen
| PHF | 31.00EUR | +0.32% | 0 € | |
Tradegate
| PHF | 30.85EUR | -0.80% | 0 € |
Basic data
Market Cap (EUR)
46,53,59,218
Market Cap (USD)
54,01,10,513
Net sales (EUR)
23,65,00,000
Net sales (USD)
27,44,89,322
Free-Float
31.97 %
Free-Float capitalization (EUR)
15,01,76,045
Free-Float capitalization (USD)
17,42,99,031
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 54Cr | ||
| +3.65% | +2.96% | -5.90% | +62.98% | 22TCr | ||
| -1.50% | -3.59% | +44.78% | +91.03% | 12TCr | ||
| +3.24% | -2.12% | -25.14% | -43.92% | 11TCr | ||
| -0.15% | -5.14% | -29.23% | -36.06% | 8.34TCr | ||
| -0.76% | -5.53% | -27.12% | -8.74% | 5.89TCr | ||
| +0.12% | -8.19% | -32.29% | -29.39% | 4.39TCr | ||
| -1.03% | -1.21% | +0.29% | +102.54% | 4.27TCr | ||
| -1.11% | -4.08% | +0.40% | +181.35% | 3.95TCr | ||
| -0.07% | -8.56% | -17.61% | -4.43% | 3.42TCr | ||
| Average | +0.25% | -5.27% | -10.20% | +35.04% | 7.49TCr | |
| Weighted average by Cap. | +1.11% | -4.53% | -6.50% | +35.10% |
Historical Quotes: PHARMAGEST INTER.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- EQS Stock
- Stock
- Quotes PHARMAGEST INTER.
Select your edition
All financial news and data tailored to specific country editions

















